MetaCap

Who Owns Vir Biotechnology Stock?

NASDAQ: VIRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.39-0.48 (-5.41%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
80.89%
Institutional holders
365
  • Institutions 80.9%
  • Insiders 6.6%
  • Public and other 12.5%

Who owns Vir Biotechnology stock?

Institutional investors own about 80.9% of Vir Biotechnology's shares, spread across 365 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.63% of VIR.

The largest institutional holders are Blackrock Inc. (13.11%), Arch Venture Management, Llc (7.41%) and Vanguard Portfolio Management LLC (7.02%). Together, the top 10 institutions control 54.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their VIR positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of VIR

Vir Biotechnology top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.22.45M13.11%+8.6%
Arch Venture Management, Llc12.69M7.41%-1.7%
Vanguard Portfolio Management LLC12.02M7.02%+4.6%
SB Investment Advisers (UK) LTD10.95M6.39%0.0%
GSK plc8.55M4.99%0.0%
State Street Corporation7.82M4.57%-21.5%
Vanguard Capital Management LLC6.45M3.77%+0.9%
Point72 Asset Management, L.P.5.67M3.31%+190.3%
Dimensional Fund Advisors LP3.32M1.94%+6.3%
Geode Capital Management, LLC3.02M1.76%-9.8%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of VIR

Vir Biotechnology top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund4.85M2.83%
iShares Trust-iShares Russell 2000 ETF3.53M2.06%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund3.48M2.03%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.55M1.49%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund2.00M1.17%
VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund1.76M1.03%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.40M0.82%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.35M0.79%
iShares Trust-iShares Russell 2000 Value ETF1.28M0.75%
SPDR SERIES TRUST-State Street SPDR Portfolio S&P 600 Small Cap ETF1.16M0.68%

Frequently asked questions

Who is the largest shareholder of Vir Biotechnology?

Blackrock Inc. is the largest institutional shareholder of VIR, owning 13.11% of shares outstanding (22.45M shares) as of its latest 13F filing.

What percentage of Vir Biotechnology is owned by institutions?

Institutions own about 80.9% of VIR shares and 86.6% of the public float.

How much of Vir Biotechnology do insiders own?

Insiders, such as officers and directors, own about 6.63% of VIR shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related